脂质乳剂用于急性有机磷杀虫剂中毒——一项初步观察性安全性研究
该研究为开放标签初步研究,纳入40例症状性有机磷中毒患者,在标准治疗基础上给予20%脂质乳剂100 mL静脉输注,监测血流动力学、血液学及生化参数变化,并与历史对照组比较。结果显示:脉搏率、收缩压、舒张压、平均动脉压及血液学、生化参数均无显著变化,未观察到不良反应;与历史对照相比,死亡率无变化,但机械通气时间、住院时间缩短,高钠血症早期缓解。作者认为脂质乳剂可能对该适应证安全,需大型随机对照试验评估临床疗效。
要点
- 40例症状性有机磷中毒患者在标准治疗基础上接受20%脂质乳剂100 mL静脉输注,未观察到不良反应。
- 用药后脉搏率、收缩压、舒张压、平均动脉压均无显著变化。
- 用药后血液学和生化参数无显著变化。
- 与历史对照组相比死亡率无变化,但机械通气时间、住院时间缩短,高钠血症早期缓解。
- 作者认为脂质乳剂可能对该适应证安全,需大型随机对照试验评估临床疗效。
适用人群与场景
- 症状性有机磷中毒且符合纳入和排除标准的患者。
处置流程与药物剂量
- 在标准治疗基础上,经知情同意后给予20%脂质乳剂100 mL静脉输注。
研究设计与关键结果
- 研究类型:开放标签初步研究;样本量:40例症状性有机磷中毒患者;干预:在标准治疗基础上给予20%脂质乳剂100 mL静脉输注;对照:历史对照组。
- 主要安全性结果:脉搏率、收缩压、舒张压、平均动脉压均无显著变化;血液学和生化参数无显著变化;未观察到不良反应。
- 与历史对照组比较:死亡率无变化;机械通气时间缩短、住院时间缩短、高钠血症早期缓解。
证据类型、等级与局限
- 证据类型:开放标签初步观察性安全性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,血流动力学参数无变化且无不良反应提示脂质乳剂可能对该适应证安全。
- 作者指出,需要大型随机对照试验评估临床疗效。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: Organophosphate (OP) poisoning is an important public health concern in South-Asia especially in the farming population. Treatment of OP poisoning has remained unchanged since decades and case fatality is 10-40% despite best supportive care, anticholinergic agents and oximes. A new antidote is the need of the hour. Lipid emulsion being inexpensive, easily available and effective in management of other lipid soluble toxins may be a novel option. However, safety has not been established and efficacy is limited to animal studies and case reports in humans with OP poisoning.
METHODS: An open-label pilot study was undertaken to establish the safety of lipid emulsion in OP poisoning. Patients with symptomatic OP poisoning, meeting the inclusion and exclusion criteria were treated with 100 mL of 20% intravenous lipid emulsion (after consent) in addition to standard of care. They were monitored for change in hemodynamic parameters, change in hematology and biochemical parameters at various intervals of time after initiation of therapy. Morbidity, mortality, and occurrence of adverse effects were compared with historical control group.
RESULTS: Forty patients with symptomatic OP poisoning were enrolled in the study group. No significant change in hemodynamic parameters (pulse rate, systolic, diastolic blood pressure, and mean arterial pressure) or in hematology and biochemical parameters were seen. No adverse effects were noted. Compared to historical controls, no change in mortality was noted, although there was reduced duration of mechanical ventilation, hospital stay, and early resolution of hypernatremia.
CONCLUSIONS: This study evaluates the safety of lipid emulsion in OP poisoning. Absence of change in hemodynamic parameters and adverse effects suggests lipid emulsion may be safe for this indication. Large randomized controlled trials are now required to assess clinical efficacy. ClinicalTrials.gov number: NCT03564574.
参考来源
- Chhabria BA, Bhalla A, Shafiq N, et al. Lipid emulsion for acute organophosphate insecticide poisoning - a pilot observational safety study. Clin Toxicol (Phila). 2018. PMID: 30307350. doi:10.1080/15563650.2018.1520997
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。